Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pasteurella Vaccine (Middle East for Vaccines)
- Development stage
- Unknown
- Lead developer
- MEVAC
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Pasteurella Vaccine (Middle East for Vaccines) is an inactivated veterinary vaccine developed by Middle East for Vaccines (MEVAC) for the prevention of pasteurellosis in ruminants, including cattle, sheep, and goats. The vaccine is designed to induce a protective immune response against *Pasteurella* species, primarily *Pasteurella multocida* and *Mannheimia haemolytica*, which are the causative agents of significant respiratory and systemic diseases such as hemorrhagic septicemia and pneumonic pasteurellosis (shipping fever). By delivering inactivated bacterial antigens, the vaccine stimulates the animal's immune system to produce specific antibodies, thereby providing active immunity and reducing the morbidity and mortality associated with these infections in livestock populations.
- Brand names
- MEVAC Pasteurella
- Other names
- pasteurella vaccine-Middle East for Vaccines-veterinary vaccine-Pasteurellosis (Ruminants)Pasteurellosis Vaccine (Ruminants)
02
Targets
Mannheimia haemolytica antigensP. multocida (Pasteurella multocida)
Beyond the preview
Go deeper on Pasteurella Vaccine (Middle East for Vaccines).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pasteurella Vaccine (Middle East for Vaccines).